Treatment of Follicular Lymphoma With High Dose Therapy and Stem Cell Support Followed by Rituximab and Alpha Interferon
Clinical trial NCT03069248 · COMPLETED
Trial details
- NCT number
- NCT03069248
- Sponsor
- Sunnybrook Health Sciences Centre
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2000-06-01
- Primary completion
- 2009-09-17
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.